{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T02:50:53Z","timestamp":1786675853328,"version":"build-2736575974"},"reference-count":45,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS32\/2025"],"award-info":[{"award-number":["DS32\/2025"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Tyrosinase is a key enzyme in melanogenesis, playing an important role in skin, hair, and eye pigmentation, as well as in the enzymatic browning of fruits and vegetables. Excessive tyrosinase activity leads to hyperpigmentation and other dermatological problems, and it also causes losses in the food industry. For this reason, tyrosinase inhibitors have become the subject of intensive research in medicine, cosmetology, and food technology. Among various inhibitors, compounds containing ketone and hydroxyl groups draw special attention, because they have the ability to chelate copper ions in enzyme\u2019s active center or block access to it. This article discusses the possible mechanisms of action, based on molecular modeling of interaction of PDB database retrieved model of enzyme with known natural inhibitors\u2013kojic acid and tropolone, as well as 6-hydroxyimino derivatives of imidazo[1,2-a]imidazole-5-ones. The results suggest that the model of enzyme\u2013ligand interaction can be useful in establishing affinity to tyrosinase of new natural and synthetic inhibitors, which can have broad applications in various fields, particularly in medicine and cosmetology, with promising prospects for further development.<\/jats:p>","DOI":"10.3390\/molecules30204079","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T06:06:32Z","timestamp":1760508392000},"page":"4079","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hydroxyketone Tyrosinase Inhibitors: Mechanism of Action, Applications and Perspectives in Depigmentation and Melanoma Therapy"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-964X","authenticated-orcid":false,"given":"Barbara","family":"Bogda\u0144ska","sequence":"first","affiliation":[{"name":"Doctoral School, Medical University of Lublin, 20-093 Lublin, Poland"},{"name":"Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University of Lublin, Chodzki 4A, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9306-7463","authenticated-orcid":false,"given":"Dmytro","family":"Khylyuk","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, Chodzki 4A, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2373-9479","authenticated-orcid":false,"given":"Dariusz","family":"Matosiuk","sequence":"additional","affiliation":[{"name":"Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University of Lublin, Chodzki 4A, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.53584\/wiadchem.2023.05.1","article-title":"Peptides and peptidomimetics as inhibitors of tyrosinase","volume":"77","author":"Latajka","year":"2023","journal-title":"Wiad. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ha\u0142dys, K., Goldeman, W., Anger-G\u00f3ra, N., Rossowska, J., and Latajka, R. (2021). Monosubstituted acetophenone thiosemicarbazones as potent inhibitors of tyrosinase: Synthesis, inhibitory studies, and molecular docking. Pharmaceuticals, 14.","DOI":"10.3390\/ph14010074"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zolghadri, S., Beygi, M., Mohammad, T.F., Alijanianzadeh, M., Pillaiyar, T., Garcia-Molina, P., Garcia-Canovas, F., Munoz-Munoz, J., and Saboury, A.A. (2023). Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises. Biochem. Pharmacol., 212.","DOI":"10.1016\/j.bcp.2023.115574"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ni, X., Luo, X., Jiang, X., Chen, W., and Bai, R. (2025). Small-molecules tyrosinase inhibitors for treatment of hyperpigmentation. Molecules, 30.","DOI":"10.3390\/molecules30040788"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ashraf, J., Mughal, E.U., Alsantali, R.I., Obaid, R.J., Sadiq, A., Naeem, N., Anser, A., Massadaq, A., Javed, Q., and Sumrra, S.H. (2021). Structure-based designing and synthesis of 2-phenylchromone derivatives as potent tyrosinase inhibitors: In vitro and in silico studies. Bioorg. Med. Chem., 35.","DOI":"10.1016\/j.bmc.2021.116057"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/fft2.494","article-title":"Structural insights and biological activities of flavonoids: Implications for novel applications","volume":"6","author":"Tang","year":"2025","journal-title":"Food Front."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"115655","DOI":"10.1016\/j.ejmech.2023.115655","article-title":"Recent advances in triazoles as tyrosinase inhibitors","volume":"259","author":"Mermer","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13428","DOI":"10.1021\/acs.jmedchem.0c00994","article-title":"Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations","volume":"63","author":"Roulier","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kim, H.D., Choi, H., Abekura, F., Park, J.Y., Yang, W.S., Yang, S.H., and Kim, C.H. (2023). Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098226"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Logesh, R., Prasad, S.R., Chipurupalli, S., Robinson, N., and Mohankumar, S.K. (2023). Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities. Biochim. Biophys. Acta. Rev. Cancer, 1878.","DOI":"10.1016\/j.bbcan.2023.188968"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Slominski, R.M., Sarna, T., P\u0142onka, P.M., Raman, C., Bro\u017cyna, A.A., and Slominski, A.T. (2022). Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.842496"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jeon, H.J., Kim, K., Kim, C., and Lee, S.E. (2023). Antimelanogenic Effects of Curcumin and Its Dimethoxy Derivatives: Mechanistic Investigation Using B16F10 Melanoma Cells and Zebrafish (Danio rerio) Embryos. Foods, 12.","DOI":"10.3390\/foods12050926"},{"key":"ref_13","first-page":"421","article-title":"Flavonoids as tyrosinase inhibitors in in silico and in vitro models: Basic framework of SAR using a statistical modelling approach","volume":"37","author":"Jakimiuk","year":"2021","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lee, K.E., Bharadwaj, S., Sahoo, A.K., Yadava, U., and Kang, S.G. (2021). Determination of tyrosinase-cyanidin-3-O-glucoside and (\u2212\/+)-catechin binding modes reveal mechanistic differences in tyrosinase inhibition. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-03569-1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/ijms10062440","article-title":"An updated review of tyrosinase inhibitors","volume":"10","author":"Chang","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-6634-9_5","article-title":"Computer-Aided Drug Design methods","volume":"1520","author":"Yu","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"106324","DOI":"10.1016\/j.ejps.2022.106324","article-title":"CADD, AI and ML in drug discovery: A comprehensive review","volume":"181","author":"Vemula","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Niazi, S.K., and Mariam, Z. (2024). Computer-Aided Drug Design and Drug Discovery: A prospective analysis. Pharmaceuticals, 17.","DOI":"10.3390\/ph17010022"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/bs.apha.2025.02.002","article-title":"Challenges and limitations of computer-aided drug design","volume":"103","author":"Sur","year":"2025","journal-title":"Adv. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Baran, S.W., Bolin, S.E., Gaburro, S., van Gaalen, M.M., LaFollette, M.R., Liu, C.N., Maguire, S., Noldus, L.P.J.J., Bratcher-Petersen, N., and Barridge, B.R. (2025). Validation framework for in vivo digital measures. Front. Toxicol., 6.","DOI":"10.3389\/ftox.2024.1484895"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch. Pharmaceut. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/acs.jcim.4c01987","article-title":"Quick-and-easy validation of protein\u2013ligand binding models using fragment-based semiempirical quantum chemistry","volume":"65","author":"Bowling","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sokouti, B. (2024). Validation strategies in systems biology research. Systems Biology and In-Depth Applications for Unlocking Diseases. Principles, Tools, and Application to Disease, Academic Press.","DOI":"10.1016\/B978-0-443-22326-6.00014-6"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wunderlich, K., Suppa, M., Gandini, S., Lipski, J., White, J.M., and Del Marmol, V. (2024). Risk factors and innovations in risk assessment for melanoma, basal cell carcinoma, and squamous cell carcinoma. Cancer, 16.","DOI":"10.3390\/cancers16051016"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"116165","DOI":"10.1016\/j.ejmech.2024.116165","article-title":"Design and synthesis of 4-amino-2\u2032,4\u2032-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells","volume":"266","author":"Lazinski","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/ics.12763","article-title":"Natural sources of melanogenic inhibitors: A systematic review","volume":"44","author":"Bertol","year":"2022","journal-title":"Int. J. Cosmet. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/ol.2022.13289","article-title":"Tyrosinase suppresses vasculogenic mimicry in human melanoma cells","volume":"23","author":"Kamo","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-22539-5_10","article-title":"Targeted therapy for melanoma","volume":"167","author":"Wong","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1158\/0008-5472.CAN-20-0434","article-title":"Cooperative targeting of immunotherapy-resistant melanoma and lung cancer by an AXL-targeting antibody-drug conjugate and immune checkpoint blockade","volume":"81","author":"Boshuizen","year":"2021","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Deri, B., Kanteev, M., Goldfeder, M., Lecina, D., Guallar, V., Adir, N., and Fishman, A. (2016). The unravelling of the complex pattern of tyrosinase inhibition. Sci. Rep., 6.","DOI":"10.1038\/srep34993"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00775-025-02099-9","article-title":"Copper-chelating natural products","volume":"30","author":"Manley","year":"2025","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13020-018-0206-9","article-title":"The antityrosinase and antioxidant activities of flavonoids dominated by the number and location of phenolic hydroxyl groups","volume":"13","author":"Zuo","year":"2018","journal-title":"Chin. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hassan, M., Shahzadi, S., and Kloczkowski, A. (2023). Tyrosinase inhibitors naturally present in plants and synthetic modifications of these natural products as anti-melanogenic agents: A review. Molecules, 28.","DOI":"10.3390\/molecules28010378"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1002\/anie.201704616","article-title":"Structure of human tyrosinase related protein 1 reveals a binuclear zinc active site important for melanogenesis","volume":"56","author":"Lai","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","article-title":"Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking","volume":"37","author":"Kramer","year":"1999","journal-title":"Proteins"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hanwell, M.D., Curtis, D.E., Lonie, D.C., Vandermeersch, T., Zurek, E., and Hutchison, G.R. (2025, April 19). SOFTWARE Open Access Avogadro: An Advanced Semantic Chemical Editor, Visualization, and Analysis Platform. Available online: http:\/\/www.jcheminf.com\/content\/4\/1\/17.","DOI":"10.1186\/1758-2946-4-17"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/ci800084x","article-title":"An alternative method for the evaluation of docking performance: RSR vs RMSD","volume":"48","author":"Yusuf","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0031-9422(00)83150-7","article-title":"Inhibition of mushroom tyrosinase by tropolone","volume":"24","author":"Kahn","year":"1985","journal-title":"Phytochemistry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, flexible, and free","volume":"26","author":"Lindahl","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1021\/jo302156p","article-title":"Why the standard B3LYP\/6-31G* model chemistry should not be used in DFT calculations of molecular thermochemistry: Understanding and correcting the problem","volume":"77","author":"Kruse","year":"2012","journal-title":"J. Org. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00339-008-5021-1","article-title":"Determination of electron affinity of electron accepting molecules","volume":"95","author":"Kanai","year":"2009","journal-title":"Appl. Phys. A"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02708340","article-title":"Chemical hardness and density functional theory","volume":"117","author":"Pearson","year":"2005","journal-title":"J. Chem. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4236\/jqis.2011.13019","article-title":"The electronegativity and the global hardness are periodic properties of atoms","volume":"1","author":"Islam","year":"2011","journal-title":"J. Quantum Inf. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.bmc.2004.08.013","article-title":"Electrophilicity index as a possible descriptor of biological activity","volume":"12","author":"Parthasarathi","year":"2004","journal-title":"Bioorganic Med. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/20\/4079\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:47:28Z","timestamp":1760590048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/20\/4079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":45,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["molecules30204079"],"URL":"https:\/\/doi.org\/10.3390\/molecules30204079","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}